Menu Search
Equities

Novo Nordisk A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
N1VO34:SAO

Novo Nordisk A/S

Actions
  • Price (BRL)32.22
  • Today's Change0.57 / 1.80%
  • Shares traded42.99k
  • 1 Year change-42.93%
  • Beta--
Data delayed at least 15 minutes, as of Feb 14 2026 00:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NVO:NYQ since
announced		Transaction
value
Metsera IncDeal withdrawn30 Oct 202530 Oct 2025Deal withdrawn-85.20%9.68bn
Akero Therapeutics IncDeal completed09 Oct 202509 Oct 2025Deal completed-87.10%5.11bn
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Caixa DTVM SAas of 30 Sep 20252.97k0.00%
Credit Suisse Hedging-Griffo Wealth Management SAas of 30 Sep 2025667.000.00%
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.